Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Retention in a 10-year cohort of internationally trained family physicians licensed in Manitoba.

Mowat S, Reslerova M, Sisler J.

Can J Rural Med. 2017 Winter;22(1):13-19.

PMID:
28234604
2.

Early reversible acute kidney injury is associated with improved survival in septic shock.

Sood MM, Shafer LA, Ho J, Reslerova M, Martinka G, Keenan S, Dial S, Wood G, Rigatto C, Kumar A; Cooperative Antimicrobial Therapy in Septic Shock (CATSS) Database Research Group.

J Crit Care. 2014 Oct;29(5):711-7. doi: 10.1016/j.jcrc.2014.04.003. Epub 2014 Apr 18.

PMID:
24927984
3.

Proteomic characterization of serine hydrolase activity and composition in normal urine.

Navarrete M, Ho J, Krokhin O, Ezzati P, Rigatto C, Reslerova M, Rush DN, Nickerson P, Wilkins JA.

Clin Proteomics. 2013 Nov 15;10(1):17. doi: 10.1186/1559-0275-10-17.

4.

Reduced hospitalizations in severe, refractory congestive heart failure with peritoneal dialysis: a consecutive case series.

Rizkallah J, Sood MM, Reslerova M, Cordova F, Malik A, Sathianathan C, Estrella-Holder E, Zieroth S.

Clin Nephrol. 2013 Nov;80(5):334-41. doi: 10.5414/CN108038.

PMID:
23993167
5.

Serum creatinine measurement immediately after cardiac surgery and prediction of acute kidney injury.

Ho J, Reslerova M, Gali B, Nickerson PW, Rush DN, Sood MM, Bueti J, Komenda P, Pascoe E, Arora RC, Rigatto C.

Am J Kidney Dis. 2012 Feb;59(2):196-201. doi: 10.1053/j.ajkd.2011.08.023. Epub 2011 Oct 2.

PMID:
21967775
6.

Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypass.

Ho J, Reslerova M, Gali B, Gao A, Bestland J, Rush DN, Nickerson PW, Rigatto C.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2340-6. doi: 10.2215/CJN.01000211. Epub 2011 Sep 1.

7.

Long-term outcomes of end-stage renal disease patients admitted to the ICU.

Sood MM, Miller L, Komenda P, Reslerova M, Bueti J, Santhianathan C, Roberts D, Mojica J, Rigatto C.

Nephrol Dial Transplant. 2011 Sep;26(9):2965-70. doi: 10.1093/ndt/gfq835. Epub 2011 Feb 15.

PMID:
21324978
8.

Sodium thiosulfate-based treatment in calcific uremic arteriolopathy: a consecutive case series.

Sood AR, Wazny LD, Raymond CB, Leung K, Komenda P, Reslerova M, Verrelli M, Rigatto C, Sood MM.

Clin Nephrol. 2011 Jan;75(1):8-15.

PMID:
21176746
9.

End-stage renal disease status and critical illness in the elderly.

Sood MM, Roberts D, Komenda P, Bueti J, Reslerova M, Mojica J, Rigatto C.

Clin J Am Soc Nephrol. 2011 Mar;6(3):613-9. doi: 10.2215/CJN.01160210. Epub 2010 Dec 2.

10.

Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients.

Miller LM, Sood MM, Sood AR, Reslerova M, Komenda P, Rigatto C, Bueti J.

Int Urol Nephrol. 2010 Dec;42(4):1007-14. doi: 10.1007/s11255-010-9857-x. Epub 2010 Oct 20. Review.

PMID:
20960231
11.

Urinary biomarkers in acute kidney injury: ready for prime time?

Ho J, Reslerova M, Rigatto C.

Am J Kidney Dis. 2010 Oct;56(4):609-11. doi: 10.1053/j.ajkd.2010.08.004. No abstract available.

PMID:
20851316
12.

Peritonitis and exit site infections in First Nations patients on peritoneal dialysis.

Hildebrand A, Komenda P, Miller L, Rigatto C, Verrelli M, Sood AR, Sathianathan C, Reslerova M, Eng L, Eng A, Sood MM.

Clin J Am Soc Nephrol. 2010 Nov;5(11):1988-95. doi: 10.2215/CJN.04170510. Epub 2010 Aug 19.

13.

Adverse outcomes among Aboriginal patients receiving peritoneal dialysis.

Sood MM, Komenda P, Sood AR, Reslerova M, Verrelli M, Sathianathan C, Eng L, Eng A, Rigatto C.

CMAJ. 2010 Sep 21;182(13):1433-9. doi: 10.1503/cmaj.100105. Epub 2010 Jul 26.

14.

Creating a model for improved chronic kidney disease care: designing parameters in quality, efficiency and accountability.

Collister D, Rigatto C, Hildebrand A, Mulchey K, Plamondon J, Sood MM, Reslerova M, Arsenio J, Coudiere R, Komenda P.

Nephrol Dial Transplant. 2010 Nov;25(11):3623-30. doi: 10.1093/ndt/gfq244. Epub 2010 May 12.

PMID:
20466693
15.

Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?

Morton AR, Murphy S, Hirsch D, Leblanc M, Barré P, Lok C, Hercz G, Hodsman A, Reslerova M, Levin A.

Hemodial Int. 2010 Apr;14(2):200-10. doi: 10.1111/j.1542-4758.2009.00426.x. Epub 2010 Mar 12.

PMID:
20337745
16.

Acute kidney injury in critically ill patients infected with 2009 pandemic influenza A(H1N1): report from a Canadian Province.

Sood MM, Rigatto C, Zarychanski R, Komenda P, Sood AR, Bueti J, Reslerova M, Roberts D, Mojica J, Kumar A.

Am J Kidney Dis. 2010 May;55(5):848-55. doi: 10.1053/j.ajkd.2010.01.011. Epub 2010 Mar 19.

PMID:
20303633
17.

Atypical clinical presentation of H1N1 influenza in a dialysis patient.

Wiebe C, Reslerova M, Komenda P, Bueti J, Rigatto C, Sood MM.

Lancet. 2009 Oct 10;374(9697):1300. doi: 10.1016/S0140-6736(09)61596-8. No abstract available.

PMID:
19819394
18.

An unusual cause of acute renal failure in sickle cell disease.

Rockx MA, Gibson IW, Reslerova M.

NDT Plus. 2009 Oct;2(5):376-8. doi: 10.1093/ndtplus/sfp081. Epub 2009 Jul 22.

19.

Outcomes of chronic dialysis patients admitted to the intensive care unit.

Strijack B, Mojica J, Sood M, Komenda P, Bueti J, Reslerova M, Roberts D, Rigatto C.

J Am Soc Nephrol. 2009 Nov;20(11):2441-7. doi: 10.1681/ASN.2009040366. Epub 2009 Sep 3.

20.

Thrice weekly warfarin administration in haemodialysis patients.

Sood MM, Rigatto C, Bueti J, Lang C, Miller L, PonnamPalam A, Reslerova M, Sood A, Komenda P.

Nephrol Dial Transplant. 2009 Oct;24(10):3162-7. doi: 10.1093/ndt/gfp252. Epub 2009 Jun 1.

PMID:
19487735
21.

Toward point-of-care diagnostic metabolic fingerprinting: quantification of plasma creatinine by infrared spectroscopy of microfluidic-preprocessed samples.

Shaw RA, Rigatto C, Reslerova M, Ying SL, Man A, Schattka B, Battrell CF, Matthewson J, Mansfield C.

Analyst. 2009 Jun;134(6):1224-31. doi: 10.1039/b821442e. Epub 2009 Mar 11.

PMID:
19475152
22.

Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study.

Ho J, Lucy M, Krokhin O, Hayglass K, Pascoe E, Darroch G, Rush D, Nickerson P, Rigatto C, Reslerova M.

Am J Kidney Dis. 2009 Apr;53(4):584-95. doi: 10.1053/j.ajkd.2008.10.037. Epub 2008 Dec 13.

PMID:
19070948
23.

Guidelines for the management of chronic kidney disease.

Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, Burns K, Manns B, White C, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Jindal K, Senior P, Pannu N, Shurraw S, Akbari A, Cohn A, Reslerova M, Deved V, Mendelssohn D, Nesrallah G, Kappel J, Tonelli M; Canadian Society of Nephrology.

CMAJ. 2008 Nov 18;179(11):1154-62. doi: 10.1503/cmaj.080351. Review. No abstract available.

24.

Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).

Moe SM, Reslerova M, Ketteler M, O'neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX.

Kidney Int. 2005 Jun;67(6):2295-304.

25.

Natural history of vascular calcification in dialysis and transplant patients.

Moe SM, O'Neill KD, Reslerova M, Fineberg N, Persohn S, Meyer CA.

Nephrol Dial Transplant. 2004 Sep;19(9):2387-93. Epub 2004 Jul 13. Erratum in: Nephrol Dial Transplant. 2004 Nov;19(11):2933. Resterova, Martina [corrected to Reslerova, Martina].

PMID:
15252163
26.

Vascular calcification in dialysis patients: pathogenesis and consequences.

Reslerova M, Moe SM.

Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S96-9. Review.

PMID:
12612962
27.

Renal microvascular actions of calcitonin gene-related peptide.

Reslerova M, Loutzenhiser R.

Am J Physiol. 1998 Jun;274(6):F1078-85. doi: 10.1152/ajprenal.1998.274.6.F1078.

PMID:
9841499

Supplemental Content

Loading ...
Support Center